Cempra, Inc., a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it will present data at the European Congress of Clinical Microbiology and Infectious Diseases in Berlin, demonstrating solithromycin's potential to treat urogenital infections and combat challenging pathogens such as enterococci and Legionella pneumophila.
[More]
Gonorrhea has long been one of the most commonly-reported sexually transmitted diseases (STDs) in the U.S. and, unfortunately, with rising antimicrobial resistance, it has also become one of the most frightening for public health.
[More]
Gold nanoparticles are tiny spherical particles made out of gold atoms with sizes on nanometre scale. This is around 1,000 times smaller than the thickness of human hair.
[More]
A Johns Hopkins Children's Center survey of 102 clinicians who treat teenage girls with pelvic inflammatory disease has found that official guidelines designed to inform decisions about hospitalization versus outpatient care leave some clinicians scratching their heads.
[More]
30 years into the HIV epidemic, there is no vaccine in sight. Yet, even though there are fantastic and effective cheap and universally available drugs, and a treatment as prevention strategy is known to work, people do not wish to get tested for HIV! If everyone got tested, and treated, we could have brought the infection under control a long time ago!
[More]
NPS MedicineWise launched its policy priorities in Canberra, spreading super gonorrhea toys around Parliament House to highlight the importance of fighting antibiotic resistance.
[More]
Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA).
[More]
An abortion clinic fights to stay open amid new proposed restrictions in North Dakota while Kansas lawmakers spar over new proposed restrictions on using state money for the procedure in that state.
[More]
Infectious diseases such as malaria and syphilis can be diagnosed rapidly and reliably in the field by using a simple test developed by Canadian scientists. The test is based on the use of DNAzymes and gold nanoparticles. As the researchers report in the journal Angewandte Chemie, their test allows for the sensitive detection of bacteria, viruses, and parasites.
[More]
Many pregnant women with sexually transmitted infections aren't getting the treatment they need when they visit emergency rooms, according to a new Michigan State University study that highlights a wholly preventable risk to unborn children and raises questions about current medical guidelines.
[More]
Being comfortable in our sexuality and making choices that support our sexual health are essential to our overall well-being. Promoting sexual health includes both preventing disease and helping people find pleasure in their sexual lives.
[More]
As the number of women in the military increases, so does the need for improved gynecologic care. Military women may be more likely to engage in high-risk sexual practices, be less likely to consistently use barrier contraception, and, therefore, more likely to contract sexually transmitted infections (STIs), according to research recently released by a physician at Women & Infants Hospital of Rhode Island.
[More]
Cepheid today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert CT/NG test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments (CLIA).
[More]
Results from a Canadian study add to those of prior studies suggesting that resistance of Neisseria gonorrhoeae to the cephalosporin antibiotic cefixime is increasing worldwide.
[More]
Researchers have discovered a new compound that restores the health of mice infected with methicillin-resistant Staphylococcus aureus (MRSA), an otherwise dangerous bacterial infection. The new compound targets an enzyme not found in human cells but which is essential to bacterial survival.
[More]
Cepheid today announced that it has received clearance from the U.S. Food & Drug Administration to market Xpert CT/NG. Running on Cepheid's GeneXpert Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae. For the first time, same-day patient consultation and treatment is possible for the two most common sexually transmitted bacterial infections in the United States.
[More]
The risk for developing pelvic inflammatory disease following an intrauterine device insertion is low, irrespective of whether a woman has been screened beforehand for gonorrhea and Chlamydia, research findings show.
[More]
The risk of developing pelvic inflammatory disease (PID) following insertion of an intrauterine device (IUD) is very low, whether or not women have been screened beforehand for gonorrhea and chlamydia, according to a joint study of nearly 60,000 women by researchers at the University of California, San Francisco (UCSF), and Kaiser Permanente Northern California Division of Research.
[More]
At a time when public-sector unions across the country are fighting to hold on to generous retirement and health benefits, one of the loudest voices standing up for their rights is Dave Low. A longtime labor activist, Low carries considerable clout as executive director of the California School Employees Assn., a 215,000-member union that represents bus drivers, custodians and other school workers.
[More]
California's pediatricians-in-training are not adequately educated about the methods to prevent recurrent sexually transmitted infections in teenagers. That's the conclusion of a study from the Stanford University School of Medicine and Lucile Packard Children's Hospital examining pediatric residents' knowledge of laws governing treatment of their patients' sexual partners.
[More]